The antioxidant and antiatherogenic effects of MAK-4 in WHHL rabbits

Journal of Alternative and Complementary Medicine

Volumn 2, Issue 4, 1996, Pages 463-478

  Lee, Jae Y ^a   Hanna, Atef N ^a   Lott, John A ^a   Sharma, Hari M ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTIOXIDANT; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN;

ANIMAL; ARTERIOSCLEROSIS; ARTICLE; AYURVEDA; BLOOD; DISEASE MODEL; FEMALE; HYPERLIPIDEMIA; PHYTOTHERAPY; RABBIT;

ANIMALS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; ARTERIOSCLEROSIS; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE PEROXIDASE; HYPERLIPIDEMIAS; LIPID PEROXIDES; LIPOPROTEINS, LDL; MEDICINE, AYURVEDIC; PHYTOTHERAPY; RABBITS;

EID: 0030309182     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.1996.2.463     Document Type: Article

References (84)

1. Ardlie NG, Selley ML, Simons LA. Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis 1989;76:117-124.
2. Aviram M. Modified forms of low density lipoprotein and atherosclerosis. Atherosclerosis 1993;98:1-9.
3. Bankson DD, Kestin M, Rifai N. Role of free radicals in cancer and atherosclerosis. Clinics Lab Med 1993;13:463-480.
4. Bondy SC, Hernandez TM, Mattia C. Antioxidant properties of two Ayurvedic herbal preparations. Biochem Arch 1994;10:25-31.
5. Born GV. Recent evidence for the involvement of catecholamines and of macrophages in atherosclerotic processes (Review). Ann Med 1991;23:569-572.
6. Brandis D. Illustrations of the forest flora of northwest and central India. Delhi: Jayyed Press, 1972.
7. Bridges AB, Scott NA, Belch JJF. Probucol, a superoxide free radical scavenger in vitro. Atherosclerosis 1991;89: 263-265.
8. Bruckdorfer KR, Buckley S, Hassal DG. The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets. Biochem J 1984;223:189-196.
9. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks slowing the progression of atherosclerosis in the WHHL rabbit. Proc Natl Acad Sci USA 1987;84:7725-7729.
10. Chen H, Tappel AL. Protection by vitamin E, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to liver slices measured by oxidized heme proteins. Free Radic Biol Med 1994;16:437-444.
11. Chin JH, Azhar S, Hoffman BB. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 1992;89:10-18.
12. Daugherty A, Zweifel BS, Schonfeld G. Probucol attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. British J Pharmacol 1989;98:612-618.
13. Daugherty A, Zweifel BS, Schonfeld G. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidemic rabbits. British J. Pharmacol 1991;103:1013-1018.
14. Donnelly TM, Kelsey SF, Levine DM, Parker TS. Control of variance in experimental studies of hyperlipidemia using the WHHL rabbit. J Lipid Res 1991;32:1089-1098.
15. Dwivedi C, Sharma HM, Dobrowski S, Engineer FN. Inhibitory effects of Maharishi-4 and Maharishi-5 on microsomal lipid peroxidation. Pharmacol Biochem Behav 1991;39:649-652.
16. Engineer FN, Sharma HM, Dwivedi C. Protective effects of M-4 and M-5 on Adriamycin-induced microsomal lipid peroxidation and mortality. Biochem Arch 1992;8:267-272.
17. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the non human primate. 1. Changes that lead to fatty streak formation. Arteriosclerosis 1984;4:323-340.
18. Fenske M, Fuchs E, Probst B. Corticosteroid, catecholamine and glucose plasma levels in rabbits after repeated exposure to a novel environment or administration of (1-24) ACTH or insulin. Life Sci 1982;31:127-132.
19. Ferns GAA, Konneh M, Ånggard EE. Vitamin E: The evidence for an anti-atherogenic role. Artery 1993;20:61-94.
20. Fields JZ, Rawal PA, Hagen JF, Ing T, Wallace RK, Tomlinson PF, Schneider RH. Oxygen free radical (OFR) scavenging effects of an anti-carcinogenic natural product, Maharishi Amrit Kalash (MAK). Pharmacologist 1990;32(3):155 (Abstract).
21. Frostegard J, Nilsson J, Haegerstrand A, Hamsten A, Wigzell H, Gidlund M. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937. Proc Natl Acad Sci USA 1990;87:904-908.
22. Galle J, Bassenge E, Busse R. Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res 1990;66:1287-1293.
23. Galle J, Mulsch A, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium derived relaxing factor. Arterioscler Thromb 1991;11:198-203.
24. Gamble JS. Flora of the presidency of Madras. London: Adland and Sons, Ltd., 1979.
25. Gerrity RG. The role of the monocyte in atherogenesis. II. Migration of foam cells from atherosclerotic lesions. Am J Pathol 1981;103:191-200.
26. Glavind J, Hartmann S, Clemmesen J, Jessen KE, Dam H. Studies on the role of lipoperoxides in human pathology. II. The presence of peroxidized lipids in the atherosclerotic aorta. Acta Pathol Microbiol Scand 1952;30:1-6.
27. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis. N Engl J Med 1983;309:288-296.
28. Haberland ME, Fong D, Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 1988;241:215-218.
29. Hanna AN, Feller DR, Witiak DT, Newman HAI. Inhibition of low density lipoprotein oxidation by thyronines and probucol. Biochem Pharmacol 1992;45:753-762.
30. Hanna AN, Sundaram V, Falko JM, Stephens RE, Sharma HM. Effect of herbal mixtures MAK-4 and MAK-5 on susceptibility of human LDL to oxidation. Complementary Med Intl 1996;3(3):28-36.
31. Havel RJ, Eder HA, Bragdon JH. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955;34:1345-1353.
32. Henning B, Chow CK. Lipid peroxidation and endothelial cell injury: Implications in atherosclerosis. Free Radic Biol Med 1988;4:99-106.
33. Hessler JR, Morel DW, Lewis J, Chisolm GM. Lipoprotein oxidation and lipoprotein-induced cytotoxicity. Arteriosclerosis 1983;3:215-222.
34. Hoff HF, Chisolm GI, Morel DW, Jurgens G, Esterbauer H. Chemical and functional changes in LDL following modification by 4-hydroxynonenal. In: Cerutti PA, McCord JM, Fridovich T, (eds). Oxy-radicals in molecular biology and pathology. New York: Alan R. Liss, Inc., 1988;459-472.
35. Hooker JD. The flora of British India. London: L. Rowe and Co., 1885.
36. Hooker JD, Thomson T. Flora Indica. Dehra Dun, India: International Book Distributors, 1976.
37. Jialal I, Fuller CJ, Huet BA. The effect of alpha-tocopherol supplementation on LDL oxidation. A dose-response study. Arterioscler Thromb Vasc Biol 1995;15:190-198.
38. John D. 100 drugs of Kani tribes of India. Int J Crude Drug Res 1984;22:17.
39. Keidar S, Brook GJ, Rosenblat M, Fuhrman B, Dankner G, Aviram M. Involvement of the macrophage low density lipoprotein receptor-binding domains in the uptake of oxidized low density lipoprotein. Arterioscler Thromb 1992;12:484-493.
40. Keys JD. Chinese herbs: Their botany, chemistry, and pharmacodynamics. Rutland, VT: Charles E. Tuttle Co., Inc., 1976.
41. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Narumiya S. Prevention of atherosclerotic progression in Watanabe rabbits by probucol. Am J Cardiol 1988;62:13B-19B.
42. Kita T, Nagano Y, Yokode M, Ishii K, Kume N, Ooshima A, Yoshida H, Kawai C. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits, an animal model for familial hypercholesterolemia. Proc Natl Acad Sci USA 1987;84:5928-5931.
43. Kleinveld HA, Demacker PNM, Stalenhoef AFH. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 1994;14:1386-1391.
44. Lapenna D, Del Boccio G, Porreca E, Pennelli A, Mezzetti A, De Gioia S, Marzio L, Di Ilio C, Cuccurullo F. Effects of high-fat, cholesterol-enriched diet on the antioxidant defence mechanisms in the rabbit heart. Free Rad Res Comm 1992;17:87-96.
45. 10 and selenium protect tissues against lipid peroxidation in rat tissue slices. J Nutr 1990;120:97-104.
46. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
47. Mao SJT, Yates MT, Rechtin AE, Jackson RL, Van Sickle WA. Antioxidant activity of probucol and its analogues in hypercholesterolemic Watanabe rabbits. J Med Chem 1991;34:298-302.
48. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 1983;24:1070-1076.
49. Mukherjee H, Ray LN. Phytochemical screening of some Indian medical plant species. Part II. Int J Crude Drug Res 1986;24:187-205.
50. Nadkarni KM. Indian materia medica. Bombay: Popular Prakashan Pvt., Ltd., 1976.
51. Nagano Y, Kita T, Yokode M, Ishii K, Kume N, Otani H, Aral H, Kawai C. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits. Atherosclerosis 1989,9:453-461.
52. Nagano Y, Nakamura T, Matsuzawa Y, Cho M, Ueda Y, Kita T. Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit-long-term antiatherogenic effect and effects on established plaques. Atherosclerosis 1992;92:131-140.
53. Nairne AK. The flowering plants of western India. London: W. H. Allen and Co., Ltd., 1976.
54. Niwa Y. Effect of Maharishi 4 and Maharishi 5 on inflammatory mediators - with special reference to their free radical scavenging effect. Indian J Clin Pract 1991;8:23-27.
55. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D, Witztum JL. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 1989;86:1372-1376.
56. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986;77:641-644.
57. Patel RI. Forest flora of Melghat. Dehra Dun, India: International Book Distributors, 1968.
58. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: A potential role in recruitment and retention of monocytes/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-2998.
59. Royle JF. Illustrations of the botany and other branches of the natural history of the Himalayan mountains and the flora of Cashmere. New Delhi, India: Today and Tomorrow's Printers and Publishers, 1970.
60. Schauenberg P, Paris F. Guide to medicinal plants. New Canaan, CT: Keats Publishing, Inc., 1977.
61. Sharma H. Freedom from disease: How to control free radicals, a major cause of aging and disease. Toronto: Veda Publishing, Inc., 1993.
62. Sharma HM. Maharishi Ayur-Veda. In: Micozzi MS, ed. Fundamentals of complementary and alternative medicine. New York: Churchill Livingstone, 1996;243-257.
63. Sharma HM, Hanna AN, Kauffman EM, Newman HAI. Inhibition of low-density lipoprotein oxidation in vitro by Maharishi Ayur-Veda herbal mixtures. Pharmacol Biochem Behav 1992;43:1175-1182.
64. Sharma HM, Hanna AN, Titterington LC, Lubow GP, Stephens RE. The antioxidant activity of Maharishi Amrit Kalash (MAK-4 and MAK-5), estrogen and vitamin C. Presented at the Scientific Conference on Atherosclerosis, Thrombosis, and Proliferation, American Heart Association, Orlando, FL, February 23-26, 1994A (Abstract).
65. Sharma HM, Hanna AN, Titterington LC, Stephens RE. Effect of MAK-4 and MAK-5 on endothelial cell- and soyabean lipoxygenase-induced LDL oxidation. In: Armstrong D, ed. Free radicals in diagnostic medicine: A systems approach to laboratory technologies, clinical correlations, and antioxidant therapy. New York: Plenum Press, 1994B.
66. Sharma PV. On rasayana (promotion therapy). In: Caraka Samhita. Vol. 2. Delhi: Chaukhambha Orientalia, 1983:1-34.
67. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990;86:75-79.
68. Steinberg D. Metabolism of lipoproteins and their role in the pathogenesis of atherosclerosis. Athero Res 1988;18:1-23.
69. Steinberg D, Parthasarathy S, Carew TE. In vivo inhibition of foam cell development by probucol in Watanabe rabbits. Am J Cardiol 1988;62:6B-12B.
70. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
71. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883-3887.
72. Steinbrecher UP, Pritchard PH. Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase. J Lipid Res 1989;30:305-315.
73. Stringer MD, Gorog PG, Freeman A, Kakkar V.V. Lipid peroxide and atherosclerosis. BMJ 1989;298:281-284.
74. Sundaram V, Hanna AN, Lubow G, Falko J, Sharma HM. Increased resistance of human LDL to oxidation in hyperlipidemic patients supplemented with oral herbal mixture MAK-4. FASEB J 1995;9(3):A141 (Abstract).
75. Tanner FC, Noll G, Boulanger CM, Luscher TF. Oxidized low density lipoproteins inhibit relaxation of porcine coronary arteries. Role of scavenger receptor and endothelium-derived nitric oxide [see comments]. Circulation 1991;83:2012-2020.
76. Test methodologies, Kodak Ektachem Clinical Chemistry Products. Rochester, New York: Eastman Kodak Company, 1992.
77. Tomlinson PF Jr, Wallace RK. Superoxide scavenging of two natural products, Maharishi-4 (M-4) and Maharishi-5 (M-5). FASEB J 1991;5(5):A1284 (Abstract).
78. Uphof JC-Th. Dictionary of economic plants. New York: Stechert-Hafner Service Agency, Inc., 1968.
79. Watanabe Y, Ito T, Shiomi M, Tsujita Y, Kuroda M, Arai M, Fukami M, Tamura A. Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbits. Biochim Biophys Acta 1988;960:294-302.
80. Wheeler CR, Salzman JA, Elsayed NM, Omaye ST, Korte Jr DW. Automated assay for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal Biochem 1990;184:193-199.
81. Witztum J. The role of monocytes and oxidized LDL in atherosclerosis. Athero Rev 1990;2159-69.
82. Yagi K. Assay for serum lipid peroxide level and its clinical significance. In: Lipid peroxides in biology and medicine. New York: Academic Press, 1982.
83. 10 in rat erythrocytes and plasma. J Nutr 1991;121:50-56.
84. Zimetbaum P, Eder H, Frishman W. Probucol: Pharmacology and clinical application. J Clin Pharmacol 1990;30:3-9.